Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05736198 · ClinicalTrials.gov registry record
Comparison of Two Sedation Regimens for Awake Fiberoptic Intubation
A clinical trial of Awake Fiberoptic Intubation and Difficult Airway, sponsored by University of Illinois at Chicago.
- Recruiting
- Registry status
- 96
- Enrollment target
- 1
- Study location
NCT05736198: Recruiting study of Awake Fiberoptic Intubation and Difficult Airway, sponsored by University of Illinois at Chicago.
NCT05736198 is a study of Awake Fiberoptic Intubation and Difficult Airway that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 96 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05736198, a study of Awake Fiberoptic Intubation and Difficult Airway, is actively recruiting participants, sponsored by University of Illinois at Chicago.
- RECRUITING
- Registry status
- 96 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the effects of different sedation drugs used for the awake fiberoptic intubation procedure. Benzodiazapines and narcotics (such as midazolam and fentanyl) are standard drugs used for sedation during awake fiberoptic intubation. Dexmedetomidine, midazolam, and fentanyl are approved by the Food and Drug Administration (FDA) procedural sedation. These drugs might be given to the patient regardless of their participation in the study. In addition to midazolam and fentanyl study subjects will also receive either dexmedetomidine or a placebo (a salt solution that contains no drug). It is believed that dexmedetomidine will not slow down breathing as much as the combination of the valium-like drug and narcotic. In our study, we are trying to determine if this is the best drug for sedation during an awake fiberoptic procedure.
Primary Outcome
Measurement using pulse oximetry (percent saturation)
Conditions Studied
Interventions
- DRUG Dexmedetomidine
Study Locations (1)
Illinois
- University of Illinois - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2024-08-12 |
| Est. Completion | 2034-03-01 |
What NCT05736198 shows while recruiting
NCT05736198 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 96 participants, a relatively small participant target.
The record links to 2 conditions, with Awake Fiberoptic Intubation appearing as the primary indexed condition, and to 1 intervention - of which Dexmedetomidine is the first listed.
NCT05736198 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05736198 about?
NCT05736198 is a clinical study titled "Comparison of Two Sedation Regimens for Awake Fiberoptic Intubation". The purpose of this study is to examine the effects of different sedation drugs used for the awake fiberoptic intubation procedure. Benzodiazapines and narcotics (such as midazolam and fentanyl) are standard drugs used for sedation during awake fiberoptic intubation. Dexmedetomidine, midazolam, and ...
What is the current status of trial NCT05736198?
This trial is currently recruiting. The enrollment target is 96 participants. The study started on 2024-08-12. Estimated completion is 2034-03-01.
What conditions does trial NCT05736198 study?
This clinical trial studies the following conditions: Awake Fiberoptic Intubation, Difficult Airway.
What interventions are being tested in trial NCT05736198?
The interventions under investigation include: Dexmedetomidine (DRUG).
Who is sponsoring clinical trial NCT05736198?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05736198 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI